Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 3 de 3
1.
Microb Drug Resist ; 30(1): 21-26, 2024 Jan.
Article En | MEDLINE | ID: mdl-37870558

In this study, we present two cases of Klebsiella pneumoniae, one KPC-33- and one NDM-1-producing, showing resistance to cefiderocol and ceftazidime/avibactam, collected in the intensive care unit of a hospital in Northern Italy from two patients who had recently undergone lung transplantation. Whole-genome sequencing was performed to investigate the molecular features of these strains.


Carbapenem-Resistant Enterobacteriaceae , Klebsiella Infections , Humans , Ceftazidime/pharmacology , Ceftazidime/therapeutic use , Anti-Bacterial Agents/pharmacology , Klebsiella pneumoniae/genetics , Cefiderocol , Klebsiella Infections/drug therapy , Microbial Sensitivity Tests , beta-Lactamases/genetics , Bacterial Proteins/genetics , Azabicyclo Compounds/pharmacology , Azabicyclo Compounds/therapeutic use , Drug Combinations
2.
New Microbiol ; 46(1): 90-94, 2023 Feb.
Article En | MEDLINE | ID: mdl-36853826

Candida-related bloodstream infections (BSIs) represent a severe condition associated with health care in the critical patient, with an increasing incidence of Candida non-albicans species. These infections could lead to several and unusual complications in high-risk patients due to various factors, including a prolonged hospital stay and invasive medical interventions. Here we report a case of a Candida krusei septic thrombophlebitis in an ARDS patient admitted to the ICU, complicated by a late onset prostatic abscess. To our knowledge, our patient represents the first reported case of a prostatic abscess due to Candida krusei treated with pharmacological therapy alone.


Candidiasis , Extracorporeal Membrane Oxygenation , Respiratory Distress Syndrome , Humans , Abscess , Vena Cava, Superior , Candida albicans , Candidiasis/complications , Candidiasis/drug therapy , Respiratory Distress Syndrome/etiology , Respiratory Distress Syndrome/therapy
3.
New Microbiol ; 45(2): 142-147, 2022 04.
Article En | MEDLINE | ID: mdl-35699564

Millerozyma farinose is a halotolerant yeast that has recently been described as an emerging human pathogen, especially in immunocompromised patients. Both the diagnostic process and treatment options are still unclear. Here, we report a case of an immunocompetent oncological patient who developed a catheter-related bloodstream infection (CRBSI) with a concomitant respiratory tract infection caused by M. farinosa. In this report, we discuss how prompt microbiological identification and attentive evaluation of the patient's clinical status can play a significant role in the appropriate management of infections caused by uncommon fungi. MALDI-TOF technology has also substantially improved the timely diagnosis of rare fungi. Furthermore, our diagnosis was subsequently confirmed by 5.8S rRNA sequencing. In our patient, the rapid diagnosis of fungaemia was crucial, together with catheter removal and the initiation of antifungal treatment, for the patient's clinical improvement.


Bacteremia , Catheter-Related Infections , Saccharomycetales , Antifungal Agents/therapeutic use , Bacteremia/drug therapy , Catheter-Related Infections/diagnosis , Catheter-Related Infections/drug therapy , Catheters , Fungi , Humans , Saccharomycetales/genetics
...